<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00271674</url>
  </required_header>
  <id_info>
    <org_study_id>KF-01-275533</org_study_id>
    <nct_id>NCT00271674</nct_id>
  </id_info>
  <brief_title>YAG Laser Versus Punch Biopsy for the Treatment of Tattoo Skin Markers</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare patient satisfaction, clinical efficacy and adverse&#xD;
      effects of Q-switched YAG laser versus punch biopsies for the treatment of tattoo dots that&#xD;
      are applied as skin markers in relation to X-ray treatment of malignant disorders.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <condition>Tattoo Skin Markers</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Q-switched YAG laser</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years or older,&#xD;
&#xD;
          -  Skin types I-IV,&#xD;
&#xD;
          -  No previous laser treatment for the condition.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Younger than 18 years,&#xD;
&#xD;
          -  Skin types V-VI,&#xD;
&#xD;
          -  Pregnant or lactating women,&#xD;
&#xD;
          -  Previous laser treatment for the condition,&#xD;
&#xD;
          -  Recent exposure to sun or sun-beds,&#xD;
&#xD;
          -  Treatment with oral retinoids within 3 months,&#xD;
&#xD;
          -  Tendency to produce hypertrophic scars or keloids,&#xD;
&#xD;
          -  Immunosuppressive treatment or disorders&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Merete Haedersdal, MD, PhD, DrMedSci.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bispebjerg Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bispebjerg Hospital</name>
      <address>
        <city>Copenhagen</city>
        <state>Copenhagen NV</state>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2008</verification_date>
  <study_first_submitted>January 3, 2006</study_first_submitted>
  <study_first_submitted_qc>January 3, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 4, 2006</study_first_posted>
  <last_update_submitted>June 2, 2008</last_update_submitted>
  <last_update_submitted_qc>June 2, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2008</last_update_posted>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

